Abstract
Objective
Although the Japanese EuroQol instrument was developed in 1998 by a Japanese translation team, the reliability of health state valuations of the fuller questionnaire has not yet been investigated in Japan. We carried out a pilot study to investigate the reliability of health state valuations of the Japanese EuroQol instrument.
Methods
The survey was conducted twice with the fuller questionnaire of the Japanese EuroQol instrument in a class of preventive medicine. We analyzed test-retest reliability based on the health state valuations and calculated Cronbach's coefficient alpha of both tests.
Results and Conclusions
The mean valuations of 14 hypothetical health states and ‘death’ between test and retest were not significantly different by paired t-test. The reliability by calculated correlation between test and retest was 0.996 (p<0.0001). In addition, Cronbach's coefficient alpha of the first test was 0.827, and that of the second test was 0.865. Although good reliability was shown in the present study, our conclusion was limited to applications of population-based surveys because of the small number and limited subjects of the present study. Further investigations are required in the form of a population-based survey.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brooks R with EuroQol group. EuroQol: the current state of play, Health Policy 1996; 37: 53–72.
Van Agt HME, Essink-Bot ML, Krabbe PFM, Bonsel GJ. Testretest reliability of health state valuations collected with EuroQol questionnaire. Soc. Sci. Med. 1994; 39: 1537–1544.
MVH Group. The measurement and valuation of health: First report of main survey. Centra for Health Economics. York. 1994.
Badia X, Monserrat S, Roset M, Herdman M. Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual. Life Res. 1999; 8: 303–310.
Johnson JA, Ohinmaa A, Murti B, Sintonen H, Coons SJ. Comparison of Finnish and U.S.-based visual analog scale valuations of the EQ-5D measure. Med. Decis. Making. 2000; 20: 281–289.
Johnson JA, Ergo A, Coons SJ. Valuation of EuroQol (EQ-5D) in adult US sample. Pharmacoeconomics 1998; 13: 421–433.
Japanese EuroQol translation team. The development of the Japanese EuroQol instrument. J. Health Care and Society. 1998; 8(1): 109–123.
The EuroQol Group. EQ-5D user guide 6th issue. 1999.
Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, Hamashima C, Hisashige A, Tamura M. Estimating an EQ-5D population value set: the case of Japan. Health Economics (in press).
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometres. 1977; 33: 159–174.
Uly-del Groot CA, Rutten FFH, Bonsel GJ. Measurement and valuation of quality of life in economic appraisal of cancer treatment. Euro. J. Cancer. 1994; 30A: 111–117.
Carmines EG, Zeller RA. Reliability and validity assessment. SAGE publications. Bevery Hills. London. 1979.
Nunnally JC. Educational measurement and evaluation. New York. McGraw-Hill. Riley MW. 1964.
Tsuchiya A, Hasegawa H, Nishimura S, Hisashige A, Ikegami N, Ikeda N. A validity study of the Japanese EuroQol instrument. J. Health Care and Society. 1998; 8(1): 67–76.
Ikeda S, Ikegami N. on behalf of the Japanese EuroQol Tariff Project. Health status in Japanese population: results from Japanese EuroQol study. J. Health Care and Society. 1999; 9(3): 83–92.
Nawata S, Yamada Y, Ikeda S, Ikegami N. EuroQol study of the elderly general population: relationship with IADL and other attributes. J. Health Care and Society. 2000; 10(2): 75–86.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hamashima, C., Yoshida, K. A study of the reliability of health state valuations in the Japanese EuroQol instrument. Environ Health Prev Med 6, 189–191 (2001). https://doi.org/10.1007/BF02897969
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02897969